Conversion of Hypoxanthine Derivatives to Guanine Derivatives by Bacillus subtilis

By successive mutagenic treatments including transduction with bacteriophage SP–10, ultraviolet light irradiation and N-methyl-N′-nitro-N-nitrosoguanidine treatments, a mutant, strain No. 322, capable of converting exogenously supplemented hypoxanthine or inosine to guanine and guanosine, was derived from an adenine-less, IMP-producing mutant of Bacillus subtilis IAM 1145. Strain No. 322 was an adenine-leaky mutant lacking GMP-reductase, adenase, and 5′-nucleotidase. The strain effectively accumulated guanine and guanosine in the culture fluid, when grown in the presence of hypoxanthine or inosine, while it failed to convert exogenously supplemented IMP to the guanine derivatives.